20 Mar, 11:04 - Indian

Nifty Pharma 22439.15 (1.53)

Nifty Next 50 64504 (1.46)

Nifty Midcap 100 55309 (1.50)

SENSEX 75110.08 (1.22)

Nifty Bank 54047.8 (1.12)

Nifty Smallcap 100 15832.25 (0.82)

Nifty 50 23268.3 (1.16)

Nifty IT 29137 (1.95)

20 Mar, 11:04 - Global

NIKKEI 225 53372.53 (-3.38)

HANG SENG 25322.18 (-0.70)

S&P 6678.5 (0.10)


You are Here : Home > Research

30-Jan-2026

Sharda Cropchem

NP up 366% yoy to Rs 145.1 crore in Q3FY2026


'On consolidated basis

Quarter ended December 2025 compared with Quarter ended December 2024.

Net sales (including other operating income) of Sharda Cropchem has increased 38.68% to Rs 1288.76 crore.  Sales of Agrochemicals segment has gone up 48.44% to Rs 1,141.12 crore (accounting for 88.54% of total sales).  Sales of Non-agrochemicals segment has gone down 8.05% to Rs 147.64 crore (accounting for 11.46% of total sales).  

Profit before interest, tax and other unallocable items (PBIT) has jumped 311.94% to Rs 172.53 crore.  PBIT of Agrochemicals segment rose 1,889.11% to Rs 134.49 crore (accounting for 77.95% of total PBIT).  PBIT of Non-agrochemicals segment rose 8.30% to Rs 38.03 crore (accounting for 22.05% of total PBIT).  

PBIT margin of Agrochemicals segment rose from 0.88% to 11.79%.  PBIT margin of Non-agrochemicals segment rose fro...



Pleaselogin & subscribe to view the full report.

More Reports
  • Company Logo

    (05-Feb-2025)

    Castrol India

    Expects EBITDA margin of 22%-25% for CY25

  • Company Logo

    (10-Feb-2023)

    Deepak Nitrite

    Plans capex of about Rs 1500 crore for FY23 and FY24

  • Company Logo

    (09-Feb-2023)

    Mayur Uniquoters

    Targets revenue of Rs 1000 crore in FY24

  • Company Logo

    (31-Jan-2023)

    Tega industries

    Capex plan is US$ 30-32 million for next three years

  • Analyst Meet / AGM-Conference Call   (17-Feb-2026)

    Sharda Cropchem

    Revenue growth to be in the range of 15-20% in FY2027

  • Results-Analysis   (30-Jan-2026)

    Sharda Cropchem

    NP up 366% yoy to Rs 145.1 crore in Q3FY2026

  • Analyst Meet / AGM-Conference Call   (30-Jan-2026)

    Sharda Cropchem

    EBITDA margins to be around 18-20% in FY2026 and FY2027

  • Analyst Meet / AGM-Conference Call   (01-Nov-2025)

    Sharda Cropchem

    Expect H2FY26 to be better than H1FY26

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +